Human MOB1 expression in non-small-cell lung cancer

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Human MOB1 (hMOB1) is a homologue of a key cell cycle regulator.
• Loss of mitotic checkpoint control in mammalian cells leads to genomic instability and tumor progression.
• Genomic instability is a hallmark of cancer, including non-small-cell lung cancer (NSCLC).

Purpose of the Study:

• To investigate the expression of hMOB1 in NSCLC.
• To determine the correlation between hMOB1 expression and clinicopathologic features in NSCLC patients.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify hMOB1 mRNA levels.
• hMOB1 mRNA expression was compared between 60 NSCLC tissues and adjacent normal lung tissues.
• Expression levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA.

Main Results:

• hMOB1 mRNA expression was significantly decreased in NSCLC tissues compared to normal lung tissues (P = 0.0437).
• Decreased hMOB1 expression was particularly noted in early-stage (pT1) NSCLC compared to advanced-stage (pT4) tumors (P = 0.0362).
• No significant correlation was found between hMOB1 expression and patient age, sex, or pathological N stage.

Conclusions:

• Reduced hMOB1 mRNA expression may indicate an early stage of tumor invasion in NSCLC.
• The loss of mitotic checkpoint control mediated by hMOB1 could play a role in lung cancer development.
• hMOB1 warrants further investigation as a potential biomarker or therapeutic target in NSCLC.